Millennium Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Millennium Management’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-104,627	Closed	-$210K	–	4467
2018 Q1	$210K	Sell	104,627 -95,078	-48%	-$206K	﹤0.01%	3359
2017 Q4	$453K	Buy	+199,705	New	+$435K	﹤0.01%	3144
2017 Q2	–	Sell	-37,100	Closed	-$105K	–	4213
2017 Q1	$105K	Buy	37,100 +13,900	+60%	+$38.1K	﹤0.01%	3321
2016 Q4	$65K	Sell	23,200 -11,480	-33%	-$32.5K	﹤0.01%	3235
2016 Q3	$108K	Buy	+34,680	New	+$130K	﹤0.01%	3116

Other funds holding SPHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return

ACM

Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Millennium Management's SPHS Position: Q2 2018 in Review

Millennium Management sold out of Sophiris Bio, Inc. (SPHS) in Q2 2018, closing a stake of 104,627 shares — an estimated $210K sold.

Millennium Management first reported a position in SPHS in Q3 2016 and held it in 5 quarters. The position peaked at $453K in Q4 2017. 30 funds tracked by Wall St. Rank hold SPHS as of Q2 2018.

Millennium Management reported no remaining Sophiris Bio, Inc. position as of Q2 2018 after selling out during the quarter.
Millennium Management sold 104,627 Sophiris Bio, Inc. shares in Q2 2018, an estimated $210K.
Millennium Management first reported a position in Sophiris Bio, Inc. in Q3 2016 and held it in 5 quarters.
Millennium Management's Sophiris Bio, Inc. position peaked at $453K in Q4 2017.
30 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2018.

Based on Millennium Management's 13F filing for Q2 2018, filed 14 Aug 2018.